STAT

SEPTEMBER 19, 2024

Amid ongoing concern over the quality of medicines made in India, a major supplier of generic medicines was seen removing three truckloads of “scrap materials” from a facility that was being inspected last month by the Food and Drug Administration.

Documentation 114

Documentation FDA Generic Medicine 114

The Guardian - Pharmaceutical Industry

JANUARY 22, 2024

Roared on by the pharmaceutical industry, ministers have been using trade talks with India to push for agreement on new, extremely restrictive patent rules that would severely undermine its generic medicines industry.

Generic Medicine 72

Generic Medicine 72

STAT

JUNE 17, 2024

Patent and Trademark Office has proposed a new rule designed to stem the use of so-called patent thickets , which are wielded by pharmaceutical companies to delay the arrival of lower-cost generic medicines in the marketplace.

Generic Medicine 126

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 126

Fierce Pharma

SEPTEMBER 19, 2023

Two large Indian suppliers of generic medicines in the U.S. and beyond are at the center of the industry's M&A rumor mill this week. Torrent is looking for financial help to potentially make a bid for its larger rival Cipla, according to Reuters.

Generic Medicine 57

Generic Medicine 57

STAT

SEPTEMBER 29, 2023

A handful of the largest purveyors of generic medicines have made only halting progress to ensure their drugs are accessible for patients in low- and middle-income countries, a new analysis found.

Generic Medicine 113

Generic Medicine 113

STAT

MAY 23, 2023

But it’s a generic medicine — which means PBMs’ negotiating techniques don’t apply. Generic drugs compete on price. There’s just one problem: PBMs don’t have anything to do with that discrepancy. The chemo drug in question, Imatinib, costs $17,000 at CVS and just $72 at Cost Plus Drugs.

Generic Medicine 98

Generic Medicine 98

STAT

MARCH 1, 2024

A growing number of alternative pharmacies — such as those run by Costco, Amazon, and Mark Cuban Cost Plus Drugs — may be increasingly popular with American consumers, but a new analysis finds many of the most expensive generic medicines are unavailable, prices vary widely, and savings can be modest.

Generic Medicine 121

Generic Medicine 121

STAT

SEPTEMBER 14, 2023

In explaining its new policy statement , the FTC noted that some drug companies have failed to follow requirements for listing patents in the so-called Orange Book in hopes of thwarting competition from lower-cost generic medicines.

Generic Medicine 129

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies FDA 129

STAT

MARCH 21, 2023

A leaked version of the agreement already sparked concerns last year that the proposed deal would impede the supply of affordable generic medicines in poor countries around the world. More than 200 civil society and patient advocacy groups are urging the U.K. Now, the groups are upset that the involvement of Harjinder Kang, the U.K.

Generic Medicine 100

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 100

The Guardian - Pharmaceutical Industry

FEBRUARY 7, 2024

Britain is pushing for patent changes that could increase the cost of Indian generic drugs, diverting more of the NHS budget to big pharma India is known as the “ pharmacy of the world ”, supplying vital generic medicines at low prices to health services including the NHS.

Generic Medicine 86

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 86

STAT

NOVEMBER 3, 2022

A leaked draft version of a trade agreement being negotiated between the United Kingdom and India has sparked concern among civil society and patient advocacy groups that the proposed deal would impede the supply of affordable generic medicines in poor countries around the world.

Generic Medicine 100

Generic Medicine 100

STAT

NOVEMBER 7, 2023

The move comes two months after the FTC issued a policy statement noting some drug companies have failed to follow requirements for listing patents in the Food and Drug Administration’s Orange Book in hopes of thwarting competition from lower-cost generic medicines. Continue to STAT+ to read the full story…

Generic Medicine 120

Generic Medicine 120

The Guardian - Pharmaceutical Industry

AUGUST 15, 2023

Indian Medical Association says that testing is substandard in the manufacture of generic medicines with ‘no guarantee of quality’ Indian doctors have been told they can no longer prescribe branded drugs for their patients, provoking vehement protest from the Indian Medical Association [IMA].

Generic Medicine 59

Generic Medicine 59

STAT

JULY 21, 2023

The review comes in response to an inspection of Synapse facilities by Spanish regulators, who raised “serious concerns about the validity and reliability” of clinical trial data generated by the company.

Generic Medicine 98

Generic Medicine FDA 98

European Pharmaceutical Review

APRIL 25, 2024

Main drivers for the market were reported to be rising popularity of generics together with blockbuster and other small-molecule drugs going off-patent globally. Overall, increasing demand for generic medicines will be a significant factor for growth.

Packaging 98

Packaging Generic Medicine Vaccines 98

European Pharmaceutical Review

JULY 1, 2024

Additionally, approval was recommended two generic medicines: Enzalutamide Viatris (enzalutamide) to treat prostate cancer, and Nilotinib Accord (nilotinib) was also recommended to treat Philadelphia chromosome positive chronic myelogenous leukaemia.

Generic Medicine 106

Generic Medicine Vaccines 106

European Pharmaceutical Review

JANUARY 30, 2024

Ryzneuta (efbemalenograstim alfa) received a positive opinion from the CHMP as a medicine to reduce the duration of neutropenia and the incidence of febrile neutropenia due to chemotherapy. Additionally, a positive opinion for Niapelf (paliperidone), a generic medicine for schizophrenia was adopted in the meeting.

Generic Medicine 98

Generic Medicine Chemotherapy Hospitals 98

European Pharmaceutical Review

FEBRUARY 26, 2024

Other positive opinions by the CHMP Zynyz* (retifanlimab) as a treatment for Merkel cell carcinoma, a type of skin cancer Pyzchiva (ustekinumab), a biosimilar used to treat plaque psoriasis The generic medicine Apremilast Accord (apremilast), for psoriatic arthritis, psoriasis and Behçet’s disease, a rare type of inflammatory disease Generic medicine (..)

Generic Medicine 98

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

Pharmaceutical Technology

DECEMBER 15, 2022

Europe also enforces rigid pricing policies for essential medicines to be available at the lowest possible price. These factors combined affect the commercial viability of generic medicines, with some European drugmakers already warning that they may stop making cheap generic medicines.

Generic Medicine 98

Generic Medicine Hospitals 98

European Pharmaceutical Review

APRIL 30, 2024

The committee also recommended the biosimilar medicine Wezenla (ustekinumab) to treat of plaque psoriasis. Generic medicine Eribulin Baxter (eribulin) was also granted a positive opinion by the committee, to treat breast cancer and liposarcoma. This covers paediatric plaque psoriasis, psoriatic arthritis and Crohn’s disease.

Generic Medicine 98

Generic Medicine Chemotherapy Hospitals FDA 98

pharmaphorum

DECEMBER 15, 2020

“Now more than ever, it is our responsibility as a sector to ensure affordable access to healthcare and enable the future longevity of medicine development and supply.”. The generics medicines sector can, too, play a substantial part in discovering new areas for licensed products to be used in. Delivery of essential medicines.

Generic Medicine 74

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Vaccines 74

European Pharmaceutical Review

MARCH 14, 2023

The CJEU stressed that identical medicinal products are not those that are only therapeutically equivalent (as generics are to reference products), but they should be identical in all respects.

Packaging 98

Packaging Generic Medicine Labelling Pharmaceutical Companies 98

European Pharmaceutical Review

SEPTEMBER 21, 2022

Biosimilar medicine Ximluci (ranibizumab) for the treatment of neovascular age-related macular degeneration, a progressive retinal macular disease, causing gradual vision impairment, mainly in the elderly population.

Generic Medicine 98

Generic Medicine Vaccines 98

Pharmaceutical Technology

FEBRUARY 28, 2023

The company offers generic medicines and biosimilars through Sandoz. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, hematologic diseases, solid tumors, immune disorders, and infections, among others.

Generic Medicine 68

Generic Medicine Immunization 68

pharmaphorum

OCTOBER 26, 2021

Novartis revealed today that it may consider divesting its generic medicines subsidiary Sandoz – amongst other options – which would further narrow its focus to innovative medicines.

Generic Medicine 116

Generic Medicine Vaccines 116

European Pharmaceutical Review

NOVEMBER 14, 2022

New generic medicine Pirfenidone Viatris (pirfenidone), received a positive opinion to treat idiopathic pulmonary fibrosis (IPF), a chronic and progressive condition where the lungs become scarred and breathing becomes increasingly difficult.

Vaccines 98

Vaccines Generic Medicine 98

pharmaphorum

OCTOBER 6, 2022

” It also sees continued growth in cardiovascular and venous diseases, as well as in generic medicines, and says its new visual identity (see above) reflects its “uniqueness” as an “independent group, governed by a foundation, committed to therapeutic progress to serve patient needs.”

Generic Medicine 96

Generic Medicine Chemotherapy 96

Pharmaceutical Technology

AUGUST 26, 2022

Last year, Sandoz generated sales worth $9.6bn and served more than 100 markets across the globe with a robust presence in the US, Europe and other regions. Upon becoming a standalone company, Sandoz would progress to make investments in the main strategic regions of antibiotics, biosimilars and generic medicines.

Generic Medicine 59

Generic Medicine 59

European Pharmaceutical Review

AUGUST 25, 2022

Meanwhile, Sandoz would leverage its strong brand and sustain its leading global position by continuing to invest in the key strategic areas of Biosimilars, Antibiotics and Generic Medicines. Working to deliver on its vision of access to patients. Additional transaction details.

Generic Medicine 98

Generic Medicine 98

pharmaphorum

MARCH 14, 2022

For Sandoz, the acquisition gives it a technology platform in an area of the generic medicines market with a relatively high barrier to entry, as developing inhaled medicines poses “comparatively high technical complexity,” according to Sandoz chief executive Richard Saynor.

Generic Medicine 97

Generic Medicine 97

European Pharmaceutical Review

JANUARY 30, 2023

Four new medicines recommended for approval The CHMP recommended granting a marketing authorisation for Sotyktu (deucravacitinib) for the treatment of moderate to severe plaque psoriasis in adults. Sitagliptin/Metformin hydrochloride Sun (sitagliptin/metformin hydrochloride) for the treatment of type 2 diabetes mellitus.

Generic Medicine 96

Generic Medicine 96

European Pharmaceutical Review

JULY 29, 2024

These medicines were recommended by the CHMP to treat plaque psoriasis, paediatric plaque psoriasis, psoriatic arthritis, ulcerative colitis and Crohn’s disease. Tuznue (trastuzumab) for breast and gastric cancer.

Generic Medicine 52

Generic Medicine 52

European Pharmaceutical Review

APRIL 3, 2023

The committee adopted positive opinions for three generic medicines: Dabigatran Etexilate Accord (dabigatran etexilate) for the prevention of venous thromboembolic events Lacosamide Adroiq (lacosamide) for epilepsy Sugammadex Adroiq (sugammadex) for the reversal of neuromuscular blockade induced by rocuronium or vecuronium.

Vaccines 98

Vaccines Chemotherapy Generic Medicine 98

pharmaphorum

JANUARY 4, 2023

It looks like Astellas has been unsuccessful in its attempt to block Pfizer’s generic medicines unit Hospira from launching a copycat version of big-selling pharmacologic stress agent Lexiscan in the US.

Generic Medicine 59

Generic Medicine FDA 59

Pharmaceutical Technology

FEBRUARY 28, 2023

The company offers generic medicines and biosimilars through Sandoz. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, hematologic diseases, solid tumors, immune disorders, and infections, among others.

Generic Medicine 40

Generic Medicine Immunization 40

European Pharmaceutical Review

JULY 25, 2023

The small molecule API market is influenced by several factors, including heightened R&D within the pharmaceutical sector, a growing prevalence of chronic illnesses and rising demand for generic medicines.

Compounding 97

Compounding Generic Medicine 97

pharmaphorum

AUGUST 25, 2022

Koye sells generic medicines, including COPD therapies such as Spirodin (doxofylline) and Spirodin-Ax (doxofylline and ambroxol), used to reduce open the airways and reduce coughing in patients with the respiratory condition.

Generic Medicine 84

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 84